OMA Guidelines Bundle

Obesity-Related Diseases 2026

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1544298

Contents of this Issue

Navigation

Page 40 of 45

41 Obesity and Pulmonary Disease OSA   ➤ For individuals with OSA and overweight or obesity, recommend comprehensive lifestyle interventions to promote weight loss.   ➤ For individuals with OSA and symptoms of excessive daytime sleepiness, insomnia, fatigue, apnea, or snoring, refer to sleep medicine for initiation and titration of positive airway pressure.   ➤ For individuals with moderate to severe OSA (apnea-hypopnea index ≥15): • Initiation and titration of positive airway pressure therapy and/or referral to sleep medicine specialist. • Consider treatment with tirzepatide. Asthma   ➤ For individuals with asthma and overweight or obesity, recommend >5% weight loss.   ➤ Assess the level of physical activity and determine whether the individual is meeting the goal of 150 minutes of moderate to vigorous physical activity per week.   ➤ If the physical activity goal is not met, identify barriers to regular physical activity and encourage behavior change to promote increased physical activity.   ➤ No specific physical activity is preferred, except for water-based activities, particularly for younger individuals.   ➤ Initiate treatment according to guidelines, limiting use of short- acting β-agonists with inhaled corticosteroids as preferred short and long-term treatment, along with long-acting β-agonists, leukotriene receptor antagonists, or long-acting muscarinic antagonists, based on asthma symptoms and pulmonary function.

Articles in this issue

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity-Related Diseases 2026